14:18:08 EDT Sat 08 Aug 2020
Enter Symbol
or Name

Login ID:
Pivot Pharmaceuticals Inc
Symbol PVOT
Shares Issued 88,679,077
Close 2019-04-25 C$ 0.40
Recent Sedar Documents

Pivot hires Harris Bricken for legal services

2019-04-25 10:12 ET - News Release

Dr. Patrick Frankham reports


Pivot Pharmaceuticals Inc. has retained law firm Harris Bricken LLP to provide the company with legal planning, regulatory support, corporate guidance and compliance strategies for the U.S. cannabis market. Harris Bricken is an international law firm with lawyers in Los Angeles, Portland, San Francisco, Seattle, Barcelona and Beijing. Harris Bricken's cannabis attorneys are recognized national leaders at the forefront of the cannabis industry.

Pivot's wholly owned U.S. subsidiary, Pivot Naturals LLC, based in Costa Mesa, Calif., was granted a temporary manufacturing Type N infusion licence by the California Department of Public Health (CDPH) in November, 2018, and a temporary transport-only distribution licence from the Bureau of Cannabis Control (BCC) in December, 2018. Harris Bricken will assist Pivot through the final process required to secure annual manufacturing and transport-only distribution licences for Pivot Naturals. Pivot's board of directors continues to submit all required information to the BCC and the CDPH. In addition, the company's former chairman, Ahmad Doroudian, will also be added to the licences due to his aggregate share ownership interest exceeding 5 per cent.

Patrick Frankham, Pivot's chief executive officer, commented: "We welcome Harris Bricken to the Pivot team to help navigate the cannabis regulations in California. As we prepare to commercialize our products in the U.S., Harris Bricken's advice and guidance will be invaluable to our board of directors."

About Pivot Pharmaceuticals Inc.

Pivot Pharmaceuticals is a science-based consumer packaged goods cannabis company engaged in the development and commercialization of health and wellness products using innovative, patent-protected drug delivery technologies. Upon receipt of a standard processor licence (pending) from Health Canada, Pivot's premium, bioavailable, stable and effective products will be manufactured at its 50,000-square-foot current good manufacturing practice facility located in Montreal, Que.

We seek Safe Harbor.

© 2020 Canjex Publishing Ltd. All rights reserved.